BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Receives Consensus Rating of “Buy” from Analysts
BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC – Get Free Report) has been given an average rating of “Buy” by the six research firms that are presently covering the company, Marketbeat reports. Six investment analysts have rated the stock with a buy recommendation. The average 12-month price target among analysts that have issued ratings on […]
BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC – Get Free Report) has been given an average rating of “Buy” by the six research firms that are presently covering the company, Marketbeat reports. Six investment analysts have rated the stock with a buy recommendation. The average 12-month price target among analysts that have issued ratings on […]
